Bacillus coagulans Oral Capsule
RxNorm 1809331
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1809331 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Bacillus coagulans Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDFPrescribable
Semantic Clinical Drug Form (SCDF):
Bacillus coagulans Oral Capsule
(Atom ID: 8255246)
Patient Education
Bacillus Coagulans
What is it? Bacillus coagulans is a type of bacteria. It is used similarly to lactobacillus and other probiotics as "beneficial" bacteria.
People take Bacillus coagulans for irritable bowel syndrome (IBS), diarrhea, gas, airway infections, and many other conditions, but there is no good scientific evidence to support these uses.
Bacillus coagulans produces lactic acid and is often misclassified as lactobacillus. In fact, some commercial products containing Bacillus coagulans are marketed as Lactobacillus sporogenes. Unlike lactic acid bacteria such as lactobacillus or bifidobacteria, Bacillus coagulans forms spores. Spores are an important factor in telling Bacillus coagulans apart from other lactic acid bacteria.
[Learn More]
* Please review the disclaimer below.